Supply Chain
With COVID-19 spreading, Trump has suggested that the increase in demand for supplies may not be due solely to the virus.
The recommendations center on redirecting the supply of the drugs from retail pharmacy settings to the hospital/acute care environment.
The coronavirus is causing hospitals to ramp up for a surge of cases while having to give up elective procedures that sustain their revenue.
The Department of Defense is releasing up to 2,000 ventilators and is making available up to 5 million N95 face masks from reserves.
If there's one silver lining, it's that, while the coronavirus has had a significant global impact, it's not as deadly as SARS or MERS.
Only 36% of vendors said they would immediately notify providers if they had a breach that involved PHI or other sensitive information.
During January and February, demand for N95 face masks surged, up 400% and 585%, respectively.
China is the world's largest supplier of active pharmaceutical ingredients, and the outbreak could be throwing a wrench into global API distribution.
The outbreak could also ultimately increase demand for hospital services, medical products and devices as well as certain drugs.
The Foundry will engage regional experts and offer an idea lab, dry and wet labs, manufacturing space, and access to modeling technology.